0.32
price down icon0.47%   -0.0015
after-market Handel nachbörslich: .31 -0.01 -3.13%
loading

Finanzdaten der In 8 Bio Inc-Aktie (INAB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
125.15%
0.083
-0.33 - - 0.33
Operating Expenses
13.78%
8.645
7.598 7.169 7.715 7.855
Benefits Costs and Expenses
8.645
- 7.169 7.715 7.855
Costs And Expenses
8.645
- 7.169 7.715 7.855
Operating Income/Loss
8.00%
-8.562
-7.928 -7.169 -7.715 -7.525
Income/Loss From Continuing Operations Before Tax
35.81%
-8.562
-13.34 -7.169 -7.715 -7.525
Income/Loss From Continuing Operations After Tax
12.69%
-8.562
-7.598 -7.169 -7.715 -7.525
Net Income/Loss
12.69%
-8.562
-7.598 -7.169 -7.715 -7.525
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,623%
43.29
1.5897 31.55 28.47 24.73
Diluted Average Shares
2,623%
43.29
1.5897 31.55 28.47 24.73
Basic Earnings Per Share
4.76%
-0.20
-0.21 -0.23 -0.27 -0.30
Diluted Earnings Per Share
4.76%
-0.20
-0.21 -0.23 -0.27 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):